Orion Biotech Opportunities Corp. (ORIA) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE VANDERBILT AVENUE, 26TH FLOOR
NEW YORK, NY 10017
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 677 - Blank Checks (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments712,474
Cash and cash equivalents712,474
Prepaid expense640,559
Total current assets:1,353,033
Noncurrent Assets
Intangible assets, net (including goodwill), including: 5,000,001
Other undisclosed intangible assets, net (including goodwill) 5,000,001
Other undisclosed noncurrent assets195,008,577
Total noncurrent assets:200,008,578
TOTAL ASSETS:201,361,611
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities81,631
Accounts payable11,631
Accrued liabilities70,000
Total current liabilities:81,631
Noncurrent Liabilities
Liabilities, other than long-term debt15,035,251
Deferred compensation liability, classified7,000,000
Derivative instruments and hedges, liabilities8,035,251
Total noncurrent liabilities:15,035,251
Total liabilities:15,116,882
Temporary equity, carrying amount200,000,000
Equity
Equity, attributable to parent, including:(13,755,271)
Accumulated deficit(13,755,771)
Other undisclosed equity, attributable to parent500
Total equity:(13,755,271)
TOTAL LIABILITIES AND EQUITY:201,361,611

Income Statement (P&L) (USD)

12/31/2022
12/31/2021
Operating expenses(553,689)
Other undisclosed operating loss(74,516)
Operating loss:(628,205)
Nonoperating income
(Investment Income, Nonoperating)
17,156
Interest and debt expense (107,400)
Income (loss) from continuing operations:(718,449)
Loss before gain (loss) on sale of properties:(718,449)
Other undisclosed net loss (6,049)
Net income (loss):(724,498)
Other undisclosed net income attributable to parent 
Net income (loss) attributable to parent:(724,498)
Preferred stock dividends and other adjustments 
Net income (loss) available to common stockholders, diluted:(724,498)

Comprehensive Income (USD)

12/31/2022
12/31/2021
Net income (loss):(724,498)
Comprehensive income (loss), net of tax, attributable to parent:(724,498)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: